biote Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Terry Weber

Chief executive officer

US$3.8m

Total compensation

CEO salary percentage15.7%
CEO tenure5.1yrs
CEO ownershipn/a
Management average tenure1.9yrs
Board average tenure1.9yrs

Recent management updates

Recent updates

biote initiated as a buy at Truist on leadership in hormone optimization; sees 138% upside

Sep 27

Biote partners with IMAC Holdings

Sep 07

CEO Compensation Analysis

How has Terry Weber's remuneration changed compared to biote's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$4mUS$601k

US$3m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$17m

Dec 31 2022US$7mUS$541k

-US$969k

Sep 30 2022n/an/a

US$3m

Jun 30 2022n/an/a

US$11m

Mar 31 2022n/an/a

US$24m

Dec 31 2021US$1mUS$1m

US$33m

Compensation vs Market: Terry's total compensation ($USD3.82M) is above average for companies of similar size in the US market ($USD2.37M).

Compensation vs Earnings: Terry's compensation has been consistent with company performance over the past year.


CEO

Terry Weber (70 yo)

5.1yrs

Tenure

US$3,816,739

Compensation

Ms. Teresa S. Weber, also known as Terry, serves as Chief Executive Officer of biote Corp. (formerly BioTe Holdings, LLC) since March 2019 and its Director since June 2018. Prior to joining Biote, Ms. Webe...


Leadership Team

NamePositionTenureCompensationOwnership
Marc Beer
Executive Chairman3.3yrsUS$1.65mno data
Teresa Weber
CEO & Director5.1yrsUS$3.82mno data
Mary Conlon
VP of Business Development2.8yrsUS$1.05m0.41%
$ 1.4m
Mary Puncochar
Head of Strategic Sales & Business Analyticsless than a yearUS$1.24m0%
$ 0
Robert Peterson
Chief Financial Officerless than a yearno datano data
Joe Butler
Chief Information Officer5.1yrsno datano data
James Gibbs
Chief People Officerless than a yearno datano data
Richard Key
Chief Digital Officer3.3yrsno datano data
Jade Beutler
Head of Nutraceuticals1.9yrsno datano data
Ross McQuivey
Chief Medical Officer & Member of Medical Advisory Board1.8yrsno datano data
Cory Rice
Chief Clinical Advisor & Member of Medical Advisory Boardno datano datano data

1.9yrs

Average Tenure

58yo

Average Age

Experienced Management: BTMD's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Marc Beer
Executive Chairman3.3yrsUS$1.65mno data
Teresa Weber
CEO & Director5.8yrsUS$3.82mno data
Ross McQuivey
Chief Medical Officer & Member of Medical Advisory Boardno datano datano data
Cory Rice
Chief Clinical Advisor & Member of Medical Advisory Boardno datano datano data
Steven Heyer
Independent Director1.9yrsUS$254.00k3.06%
$ 10.8m
Andrew Heyer
Independent Director1.9yrsUS$239.01k6.73%
$ 23.8m
Debra Morris
Independent Director1.4yrsUS$143.39k0.087%
$ 306.2k
Mickey Karram
Chair of Medical Advisory Boardno datano datano data
S. Cone
Independent Director2.7yrsUS$224.52k0.41%
$ 1.5m
Dana Jacoby
Independent Director1.9yrsUS$236.56k0.11%
$ 401.9k
Bruce Dorr
Senior Medical Advisor & Member of Medical Advisory Boardno datano datano data
Lisa Jukes
Member of Medical Advisory Boardno datano datano data

1.9yrs

Average Tenure

62yo

Average Age

Experienced Board: BTMD's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.